Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software
Energy & Infrastructure
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
DE
INT
DA
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
19 Mai 2017
Analysis, VA Automotive: Increasing costs squeezes Q1 results
Equity Research
19 Mai 2017
Analysis, Hanza: Room for improvement this year
Equity Research
17 Mai 2017
Analysis Precise Biometrics: High costs starts the new year
Equity Research
17 Mai 2017
Analysis, Kontigo Care: Rising sales
Equity Research
16 Mai 2017
Analysis, Cherry: Growth contiues in 2017
Equity Research
16 Mai 2017
Analysis, MultiDocker: High activity in slow season
Equity Research
16 Mai 2017
Analysis, Cortus: Break through and new money
Equity Research
15 Mai 2017
Analysis, Amasten Holding: 24 procent rebate
Equity Research
12 Mai 2017
Analysis, Oboya: Growth of 25 procent is reasonable...
Equity Research
04 Mai 2017
Analysis Serneke: Sold building permissions increase profits
Equity Research
04 Mai 2017
Analysis, Hedera Group: Growth but below expectations
Equity Research
04 Mai 2017
Earnings review: Serneke Q1 2017
Equity Research
03 Mai 2017
Earnings comment, TargetEveryone Q1 2017
Equity Research
03 Mai 2017
Analysis, Kancera: Application filed for clinical trial fas I
Equity Research
02 Mai 2017
Analysis, Wilson Therapeutics: Rare potential
Equity Research
02 Mai 2017
Analysis, FastPartner: Cash at hand creates opportunities
Equity Research
28 Apr 2017
Analysis, Lammhults: Strong orderbook
Equity Research
28 Apr 2017
Analysis, Maxkompetens: Acquisition adds value
Equity Research
27 Apr 2017
Preview, TargetEveryone 2017, Q1
Equity Research
21 Apr 2017
Preview: Serneke 2017, Q1
Equity Research
1
…
60
61
62
63
64